By vgreene, 28 October, 2020 Perform testing to confirm AR 1 3 aeroallergen skin prick testing or allergen specific IgE don t check food allergens3
By vgreene, 28 October, 2020 Expanded Access Program to Provide Bamlanivimab LY3819253 for the Treatment of COVID 19 NCT04603651
By vgreene, 27 October, 2020 KEY FINDINGS no benefit in overall cohort early high dose use may improve prognosis in critically ill per subgroup analysis
By vgreene, 27 October, 2020 KEY FINDINGS convalescent plasma appears safe possible mortality benefit w early use
By vgreene, 27 October, 2020 KEY FINDINGS high titer convalescent plasma significantly reduced mortality greater benefit when used w in 3 days of dx
By vgreene, 27 October, 2020 KEY FINDINGS convalescent plasma did not significantly decr time to clinical improvement
